Back to Agenda
Session 2: An Overview of the ANDA Review Process
Speaker(s)
An Overview of the ANDA Review Process
Sarah Ibrahim, PharmD, PhD
Deputy Center Director for Regulatory Programs - (CDER), U.S. Food and Drug Administration (FDA), United States
Have an account?